Genetic markers and ibrutinib vs placebo treatment in early stage chronic lymphocytic leukemia -results from the GCLLSG CLL12 trial
Armin Riecke,Eugen Tausch,Deyan Y. Yosifov,Christof Schneider,Sandra Robrecht,Adam Giza,Lothar Müller,Ursula Vehling-Kaiser,Michael J. Eckart,Werner Freier, Björn Schöttker,Tobias Gaska, Marcel Reiser,Anna-Maria Fink,Barbara F. Eichhorst,Kirsten Fischer,Michael Hallek,Petra Langerbeins,Stephan Stilgenbauer Blood（2023）
AI 理解论文
溯源树
样例
